Roche stated today that it will not let patents prevent it from licensing Tamiflu to other drug makers in order to increase the supply. As more countries stockpile the drug in the event of a pandemic, The company has been under increasing pressure to allow more manufacturers to produce the drug since Roche cannot meet the demand.
- read this article from the AP for more
ALSO: Hemispherix Biopharma believes its experimental drug--Ampligen--could be mixed with Tamiflu to triple the strength of the vaccine in order to increase the supply. Another possibility, according to Joe Howton, medical director at the Adventist Medical Center in Portland, OR, would be combining Tamiflu with a generic drug called probenecid. That could increase the length of time the drug remains in the bloodstream. Report